Switch View
© PR Newswire
22.10.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 22, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purc...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
News Preview
WILMINGTON, Del., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Peter Kuipers, will present at the 2025 UBS Global Healthcare Conference on Tuesday, November 11, 2025, at 11:00 a.m. Eastern Time....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US1266381052
CVRx Inc
CVRX
LISTED
NASDAQ
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
News Preview
MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release third quarter 2025 financial and operating re...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
22.10.2025
ISIN: US69404D1081
Pacific Biosciences of California Inc
PACB
LISTED
NASDAQ
PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5, 2025, at 4:30 pm Eastern Time....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
22.10.2025
ISIN: US68375N1037
OPKO Health Inc
OPK
LISTED
TLV
OPKO Health to Report Third Quarter 2025 Financial Results on October 29
News Preview
MIAMI, Oct. 22, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and nine months ended September 30, 2025 after the close of the U.S. financial markets on Wednesday, October 29, 2025. OPKO’s senior management will provide a business update and discuss results as well as financi...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US81727U1051
Senseonics Holdings Inc
SENS
LISTED
XASE
Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time
News Preview
GERMANTOWN, Md., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its third quarter 2025 financial resu...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US23285D1090
Cytek Biosciences Inc
CTKB
LISTED
NASDAQ
Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
FREMONT, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced it will report financial results for the third quarter 2025 after market close on Wednesday, November 5, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Paci...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US37148K1007
Generation Bio Co
GBIO
LISTED
NASDAQ
Generation Bio Announces CEO Transition
News Preview
• Geoff McDonough, MD to step down as CEO & President and become Chair of the Company’s Board of Directors...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: JP3110650003
Asahi Intecc Co Ltd
77470
LISTED
XJPX
Asahi Intecc USA Enters GI Market with Launch of Tornus ES and Fielder 18
News Preview
IRVINE, Calif., Oct. 22, 2025 /PRNewswire/ -- Asahi Intecc USA, a global leader in medical device technologies, proudly announces its official entry into the gastrointestinal (GI) market in the United States. Marking this strategic milestone, Asahi introduces two innovative endoscopic tools: Tornus ES (Endoscopic...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: VGG205281089
Charming Medical Ltd
MCTA
LISTED
NASDAQ
Charming Medical Limited Announces Closing of Initial Public Offering
News Preview
HONG KONG, Oct. 22, 2025 /PRNewswire/ -- Charming Medical Limited (Nasdaq: MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced the closing of its initial public offering (the "Offering") of 1,600,000 Class A ordinary shares, par...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Larimar Therapeutics, Inc. (NASDAQ: LRMR) resulting from allegations that Larimar Therapeutics may have issued materially misleading business information to the investing public.
So What: If you purchased...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
Deadline Approaching: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith
News Preview
Law Offices of Howard G. Smith reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”).
IF YOU ARE AN INV...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
22.10.2025
ISIN: US4448591028
Humana Inc
HUM
LISTED
NYSE
CarePlus Announces Medicare Advantage Plan Offerings for 2026
News Preview
CarePlus Health Plans, Inc., a provider of Medicare Advantage plans in Florida, today announced its 2026 Medicare Advantage plan offerings. With up to 12 plan options in each of the 20 Florida counties it serves, CarePlus remains focused on delivering robust coverage, preventive services, and exceptional member support.
“At CarePlus, we strive t...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: AU000000ANN9
Ansell Ltd
ANN
LISTED
ASX
Ansell Launches Expanded RightCycle™ Program to Help Industrial and Scientific Customers Divert PPE Waste from Landfills
News Preview
Ansell Limited (ASX: ANN), a global leader in safety solutions, today announced the launch of its expanded RightCycle™ Program. This enhanced sustainability initiative enables industrial and scientific customers to divert used PPE from landfills through recycling and a new energy recovery option using Alternative Engineered Fuels (AEFs)- a major s...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US04216R1023
Armata Pharmaceuticals, Inc.
ARMP
LISTED
XASE
Armata Pharmaceuticals Highlights Positive Results from Phase 2a diSArm Study of its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, in Late-Breaking Oral Presentation at IDWeek 2025™
News Preview
LOS ANGELES, Oct. 22, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that MoonLake Immunotherapeutics Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
The law firm of Robbins Geller Rudman & Dowd LLP announces that the MoonLake class action lawsuit – captioned Bridgewood v. MoonLake Immunotherapeutics, No. 25-cv-08500 (S.D.N.Y.) – seeks to represent purchasers or acquirers of MoonLake Immunotherapeutics (NASDAQ: MLTX) common stock and charges MoonLake as well as certain of MoonLake’s executi...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: INE044A01036
Sun Pharmaceutical Industries Ltd
SUNPHARMA
LISTED
BSE
Sun Pharma Announces Jeremy Allen as Vice President, Corporate Affairs for North America
News Preview
PRINCETON, N.J., Oct. 22, 2025 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associated companies) announced the appointment of Jeremy Allen as Vice President, Corporate Affairs for North A...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US2274831047
Cross Country Healthcare Inc
CCRN
LISTED
NASDAQ
Cross Country Marketing Team Wins Global OnCon Icon Award; Named No. 1 in the Nation
News Preview
Cross Country Healthcare (NASDAQ: CCRN) announced today that its marketing team has been named the No. 1 Marketing Team in the Nation by the 2025 OnCon Icon Awards, recognizing the best-in-class team’s creativity, innovation, measurable impact and leadership across both the healthcare and education industries and the broader marketing field.
This...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US44975P1030
I-Mab
IMAB
LISTED
NASDAQ
I-Mab To Present Positive Updated Givastomig Monotherapy Data at 2025 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference on October 23, 2025
News Preview
ROCKVILLE, Md., Oct. 22, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (I-Mab or the Company), is a global biotechnology platform company committed to accelerating access to innovative medicines for patients worldwide, today announced that updated data from the Phase 1 study (NCT04900818) of givastomig as a monotherapy in heavily pre-treated pati...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US03237H1014
Amylyx Pharmaceuticals Inc
AMLX
LISTED
NASDAQ
Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
News Preview
NEW YORK, Oct. 22, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) breached their fiduciary duties to shareholders. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US76155X1000
Revolution Medicines Inc
RVMD
LISTED
NASDAQ
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
News Preview
REDWOOD CITY, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced updated clinical data for elironrasib, a RAS(ON) G12C-selective inhibitor, in previously treated patients with KRAS G12C non...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.10.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
News Preview
Company to discontinue development of mRNA-1647 in congenital CMVCompany will continue to evaluate mRNA-1647 in ongoing Phase 2 trial in bone marrow transplant patientsCompany does not anticipate any impact to its 2025 financial guidance or its expectation of achieving breakeven in 2028CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, I...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: AU000000ANN9
Ansell Ltd
ANN
LISTED
ASX
ANSELL UNVEILS 'AXIS', IMMERSIVE CUSTOMER EXPERIENCE CENTERS DRIVING THE FUTURE OF SAFETY INNOVATION
News Preview
ISELIN, N.J., Oct. 22, 2025 /PRNewswire/ -- Ansell Limited (ASX: ANN), a global leader in safety solutions, today announced the opening of its first Ansell Xperience & Innovation Studio (AXIS) in Alpharetta, Georgia. As safety needs evolve at an unprecedented pace — driven by emerging risks, new technologies,...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: GB0009223206
Smith & Nephew PLC
SN
LISTED
LSE
UFC® and Smith+Nephew announce multi-year extension of partnership
News Preview
Smith+Nephew to continue as UFC’s Preferred Sports Medicine Technology Partner...
Themefolio
Profiler
Peergroup
© Newsfile
22.10.2025
ISIN: US68764Y2072
OS Therapies, Inc
OSTX
LISTED
XASE
OS Therapies Announces Overall and Event Free Survival Key Subgroup Data for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
News Preview
New York, New York--(Newsfile Corp. - October 22, 2025) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced additional overall and event free survival data generated from the Company's 41-patient Phase 2b clinical trial...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US1897631057
Co-Diagnostics Inc
CODX
LISTED
NASDAQ
Co-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia
News Preview
Conference attendance follows recent MOU announcement for a joint venture with a regional manufacturing and distribution company in the Kingdom of Saudi Arabia
SALT LAKE CITY, Oct. 22, 2025 /PRNewswire/ -- Co-Diagnostics,...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: IE00BGH1M568
Perrigo Company PLC
PRGO
LISTED
NYSE
Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025
News Preview
DUBLIN, Oct. 22, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2025 financial results on Wednesday, November 5th, 2025, and host a conference call beginning at 8:30 A.M. (EST)....
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US80810D1037
Schrodinger Inc
SDGR
LISTED
NASDAQ
Schrödinger to Announce Third Quarter 2025 Financial Results on November 5
News Preview
Schrödinger (Nasdaq: SDGR) will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.
The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US90337L1089
US Physical Therapy Inc
USPH
LISTED
NYSE
U.S. Physical Therapy, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call Dates
News Preview
U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three months and nine months ended September 30, 2025, on Wednesday, November 5, 2025, after the stock market closes, with the confer...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US65487U1088
Nkarta Inc
NKTX
LISTED
NASDAQ
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
News Preview
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, today announced it will be presenting a poster this Sunday in Chicago at the American College of Rheumatology (ACR) Convergence...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US05337M1045
Avadel Pharmaceuticals plc
AVDL
LISTED
NASDAQ
AVDL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Avadel Pharmaceuticals plc Is Fair to Shareholders
News Preview
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Avadel Pharmaceuticals plc (NASDAQ: AVDL) to Alkermes plc is fair to Avadel shareholders. Under the terms of the proposed transaction, Avadel shareholders will receive $18.50 per share, plus a non-transferable contingent value right entitling holders to a potential...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: JP3942400007
Astellas Pharma Inc
45030
LISTED
XJPX
Astellas Presents Preliminary Real-World VEOZAH™ (fezolinetant) Data From OPTION-VMS Phase IV Observational Study
News Preview
Extensive and growing evidence continues to reinforce fezolinetant as an effective treatment for moderate to severe VMS associated with menopause
Preliminary analysis from OPTION-VMS observational study demonstrated fezolinetant leads to statistically significan...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US6402683063
Nektar Therapeutics
NKTR
LISTED
NASDAQ
Data from REZOLVE-AD Phase 2b Study for Rezpegaldesleukin Accepted for Late-Breaking Oral Abstract Presentation at ACAAI 2025 Annual Scientific Meeting
News Preview
SAN FRANCISCO, Oct. 22, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that new data from the ongoing REZOLVE-AD Phase 2b study of rezpegaldesleukin, an IL-2 pathway agonist and regulatory T-cell (Treg) proliferator, in atopic dermatitis has been accepted for a late-breaking oral abstract...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US30052C1071
Evolus Inc
EOLS
LISTED
NASDAQ
Evolus to Report Third Quarter Financial Results on November 5, 2025
News Preview
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the U.S. financial markets close.
Evolus management will host a conference call and live webcast to discus...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: VGG312491084
Establishment Labs Holdings Inc
ESTA
LISTED
NASDAQ
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5
News Preview
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2025, before the market opens on Wednesday, November 5, 2025, and will host a confe...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US6412881053
Neuropace Inc
NPCE
LISTED
NASDAQ
NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025
News Preview
NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the third quarter of 2025 after market close on Tuesday, November 4, 2025. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacif...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US81663L2007
GeneDx Holdings Corp
WGS
LISTED
NASDAQ
GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025
News Preview
GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced data and presentations at the International Consortium on Newborn Sequencing (ICoNS), underscoring the company’s leadership in driving genomic newborn screening (gNBS) from research into real-world clinical implementation.
As the labor...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US1598641074
Charles River Laboratories International Inc
CRL
LISTED
NYSE
Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development
News Preview
Charles River Laboratories International, Inc. (NYSE: CRL) and The Francis Crick Institute (Crick) today announced a new collaboration around Antibody-Drug Conjugate (ADC) drug discovery and development, leveraging combined strengths to accelerate the development and delivery of next-generation targeted therapies.
This agreement leverages an int...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US86627T1088
Summit Therapeutics Inc
SMMT
LISTED
NASDAQ
Summit Therapeutics Raises $500 Million in Private Placement
News Preview
Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that the Company has accepted offers from multiple leading biotech institutional and individual investors to purchase an aggregate of approximately 26.68 million shares of the Company’s common stock at $18.74 per share, the closing price on Tuesday, October...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Simulations Plus Announces Preliminary Fiscal Year 2025 Results and Fiscal Year 2026 Guidance
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced preliminary results for its fiscal year 2025 and issued preliminary guidance and managemen...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US03969T1097
Arcturus Therapeutics Holdings Inc
ARCT
LISTED
NASDAQ
Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program
News Preview
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced interim results from its ongoing Phase 2 clinical trial of ARCT-032, an investigational inhaled mR...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US74340E1038
Progyny Inc
PGNY
LISTED
NASDAQ
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
News Preview
Global employers can now empower their workforces with comprehensive women’s health benefits, supported by localized expertise Global employers can now empower their workforces with comprehensive women’s health benefits, supported by localized expertise...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US2197981051
QuidelOrtho Corp
QDEL
LISTED
NASDAQ
QuidelOrtho to Report Third Quarter 2025 Financial Results
News Preview
SAN DIEGO, Oct. 22, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, announced today that it will report its financial results for the third quarter 2025 ended September 28, 2025, after the market closes on Wednesday, November 5...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: IE00B56GVS15
Alkermes Plc
ALKS
LISTED
NASDAQ
Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc
News Preview
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US6700021040
Novavax Inc
NVAX
LISTED
NASDAQ
Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy
News Preview
Agreements signed to transfer one U.S.-based facility and sell certain equipment netting $60 million in cash and resulting in future cash savings of $230 million
Novavax headquarters to remain in Gaithersburg, Md....
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US0758871091
Becton Dickinson and Co
BDX
LISTED
NYSE
BD Simplifies At-Home HPV Testing to Broaden Access to Cervical Cancer Screening Outside United States
News Preview
FRANKLIN LAKES, N.J., Oct. 22, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new self-collection solution for HPV testing in markets outside the United States. This new innovation simplifies at-home sample collection for patient...
Themefolio
Profiler
Peergroup
© PR Newswire
22.10.2025
ISIN: US1011371077
Boston Scientific Corp
BSX
LISTED
NYSE
Boston Scientific announces results for third quarter 2025
News Preview
MARLBOROUGH, Mass., Oct. 22, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.065 billion during the third quarter of 2025, growing 20.3 percent on a reported basis, 19.4 percent on an operational1 basis and 15.3 percent on an organic2 basis, all compared to the prior year...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: CA46604F1099
Izotropic Corporation
IZO
LISTED
CSE
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
News Preview
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: CA22587M1068
Cresco Labs Inc
CL
LISTED
CSE
Cresco Labs to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the third quarter ended September 30th, 2025 on Wednesday, November 5, 2025 b...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US8064071025
Henry Schein Inc
HSIC
LISTED
NASDAQ
Henry Schein to Participate in Upcoming Investor Conferences in November
News Preview
Henry Schein, Inc., (Nasdaq: HSIC) the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in November:
Stifel’s Healthcare Conference at Lotte New York Palace Hotel, New York, on November 12, 2025, at 11:20 a.m. E...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US8523123052
STAAR Surgical Co
STAA
LISTED
NASDAQ
Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors
News Preview
Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ: STAA), notified the Company’s Board of Directors (the “Board”) yesterday that it intends to call a Special Meeting of STAAR shareholders for the purpose of removing severa...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US14888U1016
Catalyst Pharmaceuticals Inc
CPRX
LISTED
NASDAQ
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
News Preview
The Company will Host a Conference Call and Webcast on Thursday, November 6, 2025, at 8:30 AM ET The Company will Host a Conference Call and Webcast on Thursday, November 6, 2025, at 8:30 AM ET...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US07725L1026
BeOne Medicines Ltd.
ONC
LISTED
NASDAQ
BeOne Medicines to Announce Third Quarter 2025 Financial Results on November 6
News Preview
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its third quarter 2025 financial results on Thursday, November 6, 2025 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET.
The live webcast of this even...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US5588681057
Madrigal Pharmaceuticals Inc
MDGL
LISTED
NASDAQ
Madrigal Pharmaceuticals to Release Third-Quarter 2025 Financial Results and Host Webcast on November 4, 2025
News Preview
CONSHOHOCKEN, Pa., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), announced today that it will release its third-quarter 2025 financial results on Tuesday, Nov. 4, 2025, prior to the o...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US92337R1014
Vera Therapeutics Inc
VERA
LISTED
NASDAQ
Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET
News Preview
Vera Therapeutics to host an investor call and Webcast to provide an ORIGIN 3 update on November 6, 2025 at 4:30 pm ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US29446K1060
Equillium Inc
EQ
LISTED
NASDAQ
Equillium to Host Ulcerative Colitis KOL Event on November 5, 2025
News Preview
Virtual webinar to feature expert insights on unmet need, treatment landscape and potential clinical utility of Aryl Hydrocarbon Receptor (AhR) modulation in ulcerative colitis Virtual webinar to feature expert insights on unmet need, treatment landscape and potential clinical utility of Aryl Hydrocarbon Receptor (AhR) modulation in ulcerative coli...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US14817C1071
Cassava Sciences Inc
SAVA
LISTED
NASDAQ
Cassava Sciences Appoints Dawn C. Bir to the Board of Directors
News Preview
AUSTIN, Texas, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (NASDAQ: SAVA, “Cassava”, the “Company”), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced the appointment of Ms. Dawn C. Bir t...
Themefolio
Profiler
Peergroup
© BusinessWire
22.10.2025
ISIN: US8835561023
Thermo Fisher Scientific Inc
TMO
LISTED
NYSE
Thermo Fisher Scientific Reports Third Quarter 2025 Results
News Preview
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 27, 2025.
Third Quarter Highlights
Third quarter revenue grew 5% to $11.12 billion.
Third quarter GAAP diluted earnings per share (EPS) was $4.27, in-line with the prior-year quarter....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.10.2025
ISIN: US09062X1037
Biogen Inc
BIIB
LISTED
NASDAQ
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025
News Preview
CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming presentations from studies evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug candidate, in systemic lupus erythematosus (SLE) to be presented at the American College of Rheumatology (ACR) Convergence 2025 (October 24-29) in...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
